--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
INM InMed Pharmaceuticals
- 5.2600
- +0.1100+2.14%
Close Dec 13 16:00 ET
- 5.2600
- 0.00000.00%
Post 20:01 ET
3.78MMarket Cap-0.69P/E (TTM)
5.2600High5.0620Low7.12KVolume5.1500Open5.1500Pre Close36.55KTurnover1.00%Turnover RatioLossP/E (Static)718.03KShares15.696052wk High0.45P/B3.76MFloat Cap2.414052wk Low--Dividend TTM713.92KShs Float3210.0000Historical High--Div YieldTTM3.85%Amplitude2.4000Historical Low5.1360Avg Price1Lot Size
InMed Pharmaceuticals Key Stats
InMed Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
InMed Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.